Michael Ellow Sells Synopsys Shares
Synopsys CRO Michael Ellow sold 2,543 shares on June 15, 2026.
Key Points
- Michael Ellow, Chief Revenue Officer of Synopsys, sold 2,543 shares on June 15, 2026.
- Synopsys, Inc. is trading at $454.38 with a market cap of $87 billion and a P/E ratio of 104.2.
- Analysts maintain a 'buy' consensus with a mean target price of $560.38, based on 26 opinions.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
On June 15, 2026, Michael Ellow, the Chief Revenue Officer of Synopsys, Inc. (NasdaqGS: SNPS), sold 2,543 shares of the company. The sale was made at the market price of $454.38 per share. This transaction was not part of a pre-planned trading program.
Insider Buying and Selling at Synopsys, Inc.
Michael Ellow's recent sale of 2,543 shares on June 15, 2026, was part of a series of insider transactions at Synopsys. Other notable transactions on the same day include Kankanwadi Sudhindra, the Deputy CFO & CAO, buying 720 shares and selling 249 shares, and Ghazi Sassine, the President and CEO, selling 14,603 shares. These transactions were not under any pre-planned trading arrangements.
Synopsys, Inc. Stock Up 1.3%
Shares of Synopsys, Inc. (NasdaqGS: SNPS) are currently trading at $454.38. The company boasts a market capitalization of approximately $87 billion, with a P/E ratio of 104.2 and a forward P/E of 26.3. Synopsys has a 52-week trading range between $376.18 and $651.73. The 50-day moving average is $476.05, and the 200-day moving average stands at $461.68. The company's beta is 1.214, indicating a moderate level of volatility compared to the market.
$SNPS stock price
Daily closing prices, year to date. Not investment advice.
Recent Earnings
Synopsys reported revenues of $8.68 billion, reflecting a growth rate of 41.9%. The company's net margin is 8.9%, and it achieved a return on equity of 3.8%. The next earnings report is scheduled for September 8, 2026.
Analysts Set New Price Targets
Several analysts have recently maintained their ratings on Synopsys. On May 28, 2026, Citigroup maintained a 'buy' rating with a price target of $610. BNP Paribas kept a 'sell' rating with a target of $450, while Stifel and B of A Securities both maintained 'buy' ratings with targets of $600. The consensus among analysts is a 'buy', with a mean target price of $560.38, based on 26 analyst opinions.
About Synopsys, Inc.
Synopsys, Inc. is a leading technology company based in Sunnyvale, California. It specializes in providing design IP solutions for the semiconductor and electronics industries. The company operates through two main segments: Design Automation and Design IP. Its offerings include digital and custom IC design solutions, verification solutions, and FPGA design products, among others. Synopsys also collaborates with Arm Holdings to develop advanced CPU solutions. Led by CEO Sassine Ghazi, the company employs around 28,000 people.
Bottom Line
Michael Ellow's recent sale of Synopsys shares is part of routine insider trading activity. Investors often track such transactions for insights, but it's important to remember that this information is backward-looking and may not reflect current positions. Synopsys continues to be a strong player in the technology sector, with analysts maintaining a positive outlook on its stock.
Get Synopsys, Inc. alerts
New 13F filings, insider trades, and analyst moves on $SNPS, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.
